Gallant Shark Tank Update (Season 11)

Gallant appeared on Shark Tank Season 11, Episode 8. The company operates in the regenerative medicine field, specifically focusing on stem cell therapy. This type of therapy uses immature cells to generate other types of blood cells, helping to repair dysfunctional or injured tissues and extend cell life. Gallant applies this technology to pets.

Founded in 2018 by Aaron Hirschhorn, Gallant had raised $11 million in funding from various investors, including Daniel Curran, Unpopular Ventures, and Slow Ventures, by August 2019.

On Shark Tank, Aaron sought $500,000 for 2% equity, valuing the company at $25 million. This valuation was notably high.

Based in San Diego, California, Gallant provides regenerative medicine services for pets. They offer three plans—Monthly, Annual, and Lifetime—covering all services at prices of $45, $395, and $990, respectively. For more information, please visit their website.

Company NameGallant
FounderAaron Hirschhorn
Founded2018
ProductRegenerative medicine business
Asked For$500k for 2% equity
Final Deal$500k for 5% equity
SharkLori Greiner Profile for Shark Tank Lori GreinerAnne Wojcicki Anne Wojcicki
Episode (Shark Tank USA)S11 E8
Air DateNov 17, 2019
Business StatusIn Business
WebsiteVisit Website
HeadquartersSan Diego, California, United States
Lifetime Worth (Sales)$15M *estimated
Buy and WatchBuy NowAmazon Prime

Another Shark Tank Pitch

How Was The Shark Tank Pitch Of Gallant?

After Aaron Hirschhorn presented his business on Shark Tank, he requested $500,000 for 2% equity, surprising all the sharks with the high valuation.

Gallant operates in two main areas: Therapeutic and Consumer Stem Cell Banking. Aaron reported that his previous company, DogVacay, had generated $100 million in sales. Currently, Gallant is spending $400,000 per month on research and development.

Kevin O’Leary made two offers:

  1. $500,000 for 2% equity plus an additional 2% in options
  2. $500,000 for 1% equity plus a royalty of $10 per kit sold

Lori Greiner and Anne Wojcicki teamed up to offer $500,000 for 8% equity. Aaron countered with a request for 4% equity. Lori then countered with 5% equity, and Aaron accepted this revised offer.

Gallant Pet Shark Tank Update

Gallant gained significant popularity following its appearance on Shark Tank, attracting many pet lovers to its services. However, shortly after, the company raised the prices of its subscription plans.

Tragically, Aaron Hirschhorn passed away in a boating accident near Miami Beach, Florida, on March 28, 2021.

The company experienced impressive growth in 2023, with annual revenue reaching $5 million, compared to previous years. Gallant expanded its team significantly as a result.

Following their Shark Tank appearance, Gallant received both funding and promotional support on national television. This exposure, combined with the trust gained from the investment, helped the company achieve $2.5 million in annual sales in 2021.

What Is the Net Worth of Gallant Pet?

Gallant Pet is currently valued at an estimated $45 million. Founded in 2018, the company has experienced significant growth, with a notable boost in sales through 2023. In 2020, Gallant secured funding from 2Future and Alumni Ventures during a venture round.

Annual Revenue by Years

Note: This report is based on our research and data so far. In this, we are only estimating the annual revenue.

YearsAnnual Revenue
2023$5M *estimated
2022$3M *estimated
2021$2.5M *estimated

Funding Reports to Date!

YearsFunding AmountInvestor
Nov 2019$500k (Seed)Anne Wojcicki and Lori Greiner
Aug 5, 2019$11M (Series A)Daniel Curran,
Unpopular Ventures
and more.

The company is dedicated to improving the lives of pets and continues to show strong growth.

Although Aaron Hirschhorn, a highly regarded entrepreneur, has passed away, the company remains operational and successful.

Gallant’s headquarters is located in San Diego, California, and the company employs between 11 and 50 people.

Yes, Gallant Pet is still in business as of April 2024.

Leave a Reply

Your email address will not be published. Required fields are marked *